Insmed (INSM) Gross Profit (2018 - 2026)
Insmed (INSM) posted quarterly Gross Profit of $258.5 million for Q1 2026, up 261.37% year-over-year from $71.5 million in Q1 2025, and up 17.72% quarter-over-quarter from $219.6 million in Q4 2025.
Insmed (INSM) Gross Profit (2018 - 2026) Analysis & Trends
Insmed's Gross Profit history runs 9 years deep, the most recent figure standing at $258.5 million for Q1 2026.
- In Q1 2026, Gross Profit rose 261.37% year-over-year to $258.5 million; the TTM figure through Mar 2026 stood at $670.5 million (up 130.04% YoY), while the FY2025 annual figure was $483.5 million, up 73.94% from the prior year.
- Gross Profit for Q1 2026 stood at $258.5 million, up from $219.6 million in the prior quarter.
- The five-year high for Gross Profit was $258.5 million in Q1 2026, with the low at $40.9 million in Q1 2022.
- The 5-year median for Gross Profit is $65.2 million (2023), against an average of $85.3 million.
- The sharpest annual moves came in 2022 and 2026: Gross Profit climbed 7.93% in 2022, then jumped 261.37% in 2026.
- Insmed's Gross Profit stood at $46.2 million in 2022, then jumped by 41.14% to $65.2 million in 2023, then increased by 19.99% to $78.3 million in 2024, then surged by 180.52% to $219.6 million in 2025, then increased by 17.72% to $258.5 million in 2026.
- Business Quant data shows INSM's Gross Profit at $258.5 million in Q1 2026, $219.6 million in Q4 2025, and $113.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 358.27 Mn |
| Jun 30, 2026 | 358.27 Mn |
| Mar 31, 2026 | 258.54 Mn |
| Mar 31, 2026 | 258.54 Mn |
| Dec 31, 2025 | 219.62 Mn |
| Dec 31, 2025 | 219.62 Mn |
| Sep 30, 2025 | 112.98 Mn |
| Sep 30, 2025 | 112.98 Mn |
| Jun 30, 2025 | 79.34 Mn |
| Jun 30, 2025 | 79.34 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 78.29 Mn |
| Dec 31, 2024 | 78.29 Mn |
| Sep 30, 2024 | 72.26 Mn |
| Sep 30, 2024 | 72.26 Mn |
| Jun 30, 2024 | 69.38 Mn |
| Jun 30, 2024 | 69.38 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Mar 31, 2024 | 58.04 Mn |